Gilead middle eastern single men
Gilead Sciences expands its
Could you highlight any specific clinical trials or research collaborations in the Middle East that Gilead is involved in, and how these initiatives contribute to advancements in healthcare in the region?. Gilead employees work to advance scientific innovation, help ensure our medicines reach those who need it and make a difference in the communities where we live and work. Some of the content on this page is not intended for users outside the U. Investor Relations. Events and Presentations. Stock Information. We’re proud to announce
This -portal is fully funded and supported by Gilead Sciences. The launch event saw the attendance of several dignitaries including Dr. Jacopo Andreose, Senior Vice President, Intercontinental and Global Patient Solutions at Gilead Sciences, said, "The pharmaceutical sector in the UAE is benefitting from a steady rise in population and net income and the roll-out of the mandatory health insurance scheme. The healthcare industry is marked by continued improvement and strategic investments in high-quality medical services by the leadership. We are keen on growing our presence in the UAE and wider region and will continue to invest in infrastructure and talent to best capitalise on these positive trends and to deliver upon the promise of our bold and transformative science. Frederico Silva, General Manager, Gilead Sciences Middle East, added, "Committed to grow as an employer of choice, our investments in state-of-the-art spaces to house our talent is reflective of our core values that guide our steadfast mission of developing and delivering innovative therapies within HIV, cancer, COVID and viral hepatitis. In our vision to create a healthier world for all people, delivering innovative medicines that aim to prevent, treat and cure life-threatening diseases, we are guided by a philosophy that by investing in our employee experience further we are able to better serve our patient communities. 
Gilead Sciences Global Workforce
Gilead Sciences, a biopharma company, achieves bold ambitions to help make the world a healthier place, leading in HIV, liver disease, cancer & inflammation. Are you sure you want to log out? You can always login again from the home screen. HIV Academy is an educational non-promotional program organized by Gilead Sciences Middle East that was started in to the present date. This year we are happy to announce the Academy will be covering HIV clinical cases that will equip HIV healthcare providers in the Middle East with the required knowledge, skills, and core competencies required to provide an up-todate evidence-based approach to the management of people living with HIV for better health outcomes and long term treatment success. An educational webinar on HIV management focusing on redefining treatment goals based on new principles of maximal and durable viral load suppression, control inflammation, incorporate PROs and reducing HIV related comorbidities. Open App. You can always login again from the home screen Yes NO. Middle Eastern Dating Middle
Gilead Sciences is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. Our collaborations extend beyond medicines alone, addressing barriers to access and inequities in healthcare systems. To truly end HIV, it takes collective efforts, and our partnerships with communities globally are key to achieving this goal. Gilead Sciences has played a pivotal role in the global fight against viral diseases, particularly in areas such as Asia, the Middle East, Russia, and Turkey. As a leading pharmaceutical company, Gilead is committed to advancing research and developing innovative treatments to tackle diseases such as HIV and viral hepatitis. This approach not only benefits patients worldwide but also contribute to the shifting panorama of disease management.